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Abstract A case–control study was conducted to
examine the association between two single nucleotide
polymorphisms (SNPs) in exon 2 of the bone morpho-
genetic protein-2 gene (BMP-2) and ossiﬁcation of the
posterior longitudinal ligament (OPLL), and to investi-
gate whether SNPs of the Ser37Ala (T/G) and the
Ser87Ser (A/G) in the BMP-2 gene are associated with
genetic susceptibility to OPLL and its severity in Chinese
subjects. The Ser87Ser (A/G) SNP has been implicated
in bone mineral density (BMD) and increases the risk of
OA in women. The Ser37Ala (T/G) SNP is associated
with BMD and the rate of bone loss in osteoporosis and
osteoporosis fractures. A total of 57 OPLL patients and
135 non-OPLL controls were studied. Radiographs of the
cervical spine were analyzed to determine the presence
and the severity of OPLL. The association of two SNPs
with the occurrence and the extent of OPLL were sta-
tistically evaluated. There was a signiﬁcant association
between the Ser37Ala (T/G) polymorphism and the
occurrence of OPLL in the cervical spine. However, no
signiﬁcant association was found between the Ser37Ala
(T/G) polymorphism and the more number of ossiﬁed
cervical vertebrae in OPLL patients. There was a sig-
niﬁcant association between the Ser87Ser (A/G)
polymorphism and the more number of ossiﬁed cervical
vertebrae in OPLL patients. However, there was no sta-
tistical difference between the Ser87Ser (A/G) SNP and
the occurrence of OPLL in the cervical spine. In addi-
tion, the Ser87Ser (A/G) polymorphism in male patients
and in female patients showed no statistical difference
between cases and controls. The present results demon-
strate that BMP-2 Gene is not only a factor associated
with the occurrence of OPLL, but also a factor related to
more extensive OPLL. The ‘‘G’’ allele in the Ser37Ala
(T/G) polymorphism is associated with the occurrence of
OPLL, but not more extensive OPLL in the cervical
spine. The ‘‘G’’ allele in the Ser87Ser (A/G) polymor-
phism promotes the extent of OPLL, whereas the ‘‘A’’
allele in the Ser87Ser (A/G) polymorphism restricts
ectopic ossiﬁcation in the cervical spine at least in
Chinese subjects.
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Ossiﬁcation of the posterior longitudinal ligament (OPLL)
has a strong genetic component, based on nation-wide
pedigree surveys [30], surveys of twins [26], and HLA
haplotype analysis [15, 22]. Because genetic factors appear
to have a crucial role in OPLL, the use of molecular genetic
studies is important to the understanding of the molecular
etiologies of OPLL and will lead to the development of
new therapeutics. However, multiple genetic and environ-
mental components must contribute to the development of
OPLL. Therefore, it has been difﬁcult to clarify all the
susceptible genes for OPLL. OPLL of the spine was ﬁrstly
reported in Japan and is a common disorder among Japa-
nese and other Asian populations. The prevalence of OPLL
in Japan is 1.9–4.3% of the general population[30 years
old [14]. OPLL has a prevalence of 0.44–8.92% and mean
prevalence of 3.08% among Chinese [8]. Heterotopic
Ossiﬁcation of the spinal ligament is the speciﬁc feature of
OPLL that causes compression of the spinal cord and leads
to various degrees of myelopathy.
The previous studies described linkage evidence in the
HLA region of chromosome 6 in 91 affected sib pairs and
identiﬁed the collagen 11A2 (COL11A2) gene as a possible
candidate [7]. Gender-speciﬁc associations indicated that
genetic factors involving COL11A2 play a speciﬁc role in
the etiology of OPLL exclusively in males [11]. Allelic
association studies between OPLL and molecular variants
in COL11A2 demonstrated that a nucleotide substitution at
intron 6(-4), a T?A substitution, is signiﬁcantly associ-
ated with OPLL, and the functional variant results in
altered splicing, which is protective in the pathogenesis of
OPLL [10]. The extensive linkage disequilibrium and
haplotype association studies have demonstrated that seven
single nucleotide polymorphisms (SNPs) of COL6A1 gene
are associated with OPLL. Among them, the intron 32
(-29) SNP is most signiﬁcantly associated with OPLL
[28]. Nakamura et al reported that the nucleotide pyro-
phosphatase gene (NPPS), which has been identiﬁed as a
cause in a mouse model of OPLL [18], is also associated
with OPLL [16]. The results demonstrated that the IVS20-
11delT allele in the NPPS gene and the A861G polymor-
phism in the leptin receptor gene are associated with more
extensive OPLL, but not with its occurrence rate [25].
Recently, many factors have been identiﬁed in bone
matrix of OPLL, including transforming growth factor b
(TGF-b), Bone morphogenetic protein (BMP), ﬁbroblast
growthfactor,andinsulin-likegrowthfactora.Amongthese
factors, only BMP was shown to induce ectopic ossiﬁcation
when implanted subcutaneously [34]. Immunohistochemi-
cal studies using a monoclonal antibody against partially
puriﬁed bovine BMP demonstrated that BMP was distri-
buted in periosteal cells and mesenchymal cells of marrow
stroma in normal human bone and chondrocytes and
mesenchymal cells of the fracture site during repair. In
addition, recombinant BMP-2 was reported to have a potent
effect on stimulating differentiation of a mesenchymal cell
lineofosteoblastlineagetocellswithosteoblasticphenotype
as evidenced by the expression of osteocalcin mRNA [36].
Fromtheseresults,itislikelythattheprimaryeffectofBMP
is to initiate the ossiﬁcation process by inducing differenti-
ation mesenchymal progenitor cells to stimulate cartilage
formation during the development of OPLL.
BMP-2 has been implicated as an important regulator of
bone metabolism [5]. The immunohistochemical studies
demonstrated that BMP-2 and TGF-b are present in ossi-
fying matrix and chondrocytes are present adjacent to
cartilaginous areas of OPLL tissues, and that BMP-2 is also
localized in mesenchymal cells with ﬁbroblastic features in
the immediate vicinity of the cartilaginous areas, and that
nonossiﬁed ligaments do not contain either of these growth
factors. It is suggested that BMP-2 plays different roles in
the different stages of development of ectopic ossiﬁcation
[5]. How the production of these factors is stimulated at the
ossifying ligaments remains unclear. Further studies are
needed to clarify the molecular mechanism of the deve-
lopment of ectopic ossiﬁcation in OPLL.
Rather, several polymorphisms of the BMP-2 gene have
been identiﬁed [24, 33]. One of the polymorphisms is a
T?G transition at nucleotide 116 in exon 2 of BMP-2,
resulting in a Ser?Ala substitution at amino acid position
37. Another Ser87Ser (A/G) polymorphism is samesense
mutation. The Ser37Ala (T/G) and Ser87Ser (A/G) poly-
morphisms are, respectively, relative to Osteoporosis and
Osteoarthritis disease [24, 33]. As a genetic disease asso-
ciated with abnormal calcium phosphate metabolism [27],
OPLL occurs with a greater frequency in genetically rela-
ted metabolic diseases. The previous studies showed that
the Ser87Ser (A/G) SNP has been implicated in bone
mineral density (BMD) and increase the risk of OA in
women [32, 33]. The Ser37Ala (T/G) SNP is associated
with BMD and the rate of bone loss in osteoporosis and
osteoporosis fractures [24].
The purpose of this study was to investigate association
of two SNPs of BMP-2 gene with susceptibility to OPLL of
the spine and its severity in Chinese patients. Association
between two SNPs of BMP-2 gene and OPLL is ﬁrstly
reported in the paper.
Subjects and methods
Disease criteria and subjects
The ethical committees of the Beijing Tiantan Hospital
Capital Medical University approved the study. Informed
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123consent was obtained from all the participants in this study.
Records of 310 consecutive spine patients with spine dis-
eases treated between May 2005 and January 2007 were
reviewed for eligibility according to the inclusion criteria.
Records of 57 patients met all criteria and formed the
clinical subjects for this study. The participants in this
study were 57 patients with OPLL and 135 control subjects
without OPLL. All 192 participants are from the Beijing
Tiantan Hospital Capital Medical University and live in
Beijing region. The average age of the patients including
32 males and 25 females is 54.9 years. Controls were also
collected on age-matched and sex-matched controls
(74 males and 61 females). In addition, all 192 participants
are from Han race of Chinese people in mainland, China.
Therefore, the cases and controls are from the same study
base and are genetically matched. Multiple authors
including an orthopedic professor, an orthopedic surgery
chief resident, and an orthopedic surgery junior resident
performed the diagnosis of OPLL. The diagnosis of OPLL
was based on radiological ﬁndings including radiographs,
computed tomogram (CT), and magnetic resonance imag-
ing (MRI) of the cervical spine according to the criteria
reported by Tsuyama [31]. OPLL in the cervical spine was
diagnosed in 57 participants: 21 with continuous type, 12
with mixed type, 19 with segmental type, and 5 with
localized type. The severity of OPLL was determined
by the number of ossiﬁed cervical vertebrae on these lateral
radiograph ﬁlms. Patients were also stratiﬁed according
to the extent of ossiﬁcation. The patients with ankylosing
spondylitis and metabolic diseases associated with
OPLL such as hypophosphate rickets/osteomalacia, diffuse
idiopathic skeletal hyperostosis (DISH), and hyperpara-
thyroidism were excluded according to radiographic and
biochemical examinations. The patients with increased
BMD and/or decreased BMD were also excluded. The
most common reason for excluding a patient from the study
was ankylosing spondylitis and metabolic diseases associ-
ated with OPLL. None of the control patients exhibited
OPLL.
Genotyping and SNPs of the BMP-2 gene
Venous blood (5 ml) was collected in tubes containing
ethylenediaminetetraacetic acid (EDTA) (50 mmol/l of
disodium salt), and genomic deoxyribonucleic acid (DNA)
was isolated with Wizard Genomic DNA Puriﬁcation Kit
(produced by Promega Corpation of USA). For the BMP-2
gene, several SNPs were already reported [24, 33]. We
analyzed two of them (Ser37Ala T/G and Ser87Ser A/G in
exon 2 of BMP-2 gene). Polymerase chain reaction (PCR)
with two primers (a sense primer 50-CTCACGTCGGT
CCTGTCC-30 and an antisense primer 50-CCCTG
CTCCATGCCTCAC-30) was performed with a standard
protocol. Reactions were performed in a total volume of
50 ll containing 0.5 lg of genomic DNA; 1 ll of each
primer (20 lM); 8 ll dCTP, dTTP, dGTP, and dATP
mixture (each 2.5 lM); 0.5 ll TAKARA LA Taq DNA
polymerase (produced by TakaRa Biotechnology dalian
Co., Ltd); 5 ll MgCl2(25 mM); 5 ll1 0 9 LA PCR Buffer
II (Mg
2+ Free); double distilled H2O (DDH2O) up to 50 ll.
The thermocycling procedure consisted of initial denatu-
ration at 95C for 5 min, 40 cycles of denaturation at 95C
for 40 s, annealing at 61C for 40 s, extension at 72C for
40 s, and a ﬁnal extension at 72C for 10 min. The PCR
products (including two SNPs in exon 2 of BMP-2 gene)
were analyzed by direct sequencing using BigDye Termi-
nator cycle sequencing on an ABI 3730XL POP7 DNA
sequencing analysis 5.2 (Applied Biosystems). The
expected size of the speciﬁc ampliﬁcation product was
393 bp.
Statistical analysis
To assess the genotypic and allelic distribution, the Chi-
square test (Fisher’s exact test) was performed. To compare
the number of ossiﬁed cervical vertebrae between two
groups, the nonparametric test (Mann–Whitney exact test)
was employed. A P value less than 0.05 was considered
statistically signiﬁcant.
Results
The distribution of genotype and allele type of two SNPs
within the BMP-2 gene in OPLL patients and controls is
shown in Table 1. Two SNPs in exon 2 of the BMP-2 gene
were accurately detected by direct sequencing using Big-
Dye Terminator cycle sequencing on an ABI 3730XL
POP7 DNA sequencing analysis 5.2 (Applied Biosystems,
Figs. 1, 2).
Table 1 Genotypic and allelic distributions of two SNPs in BMP-2
gene between OPLL patients and non-OPLL Controls
SNPs Ser37Ala (T/G) Ser87Ser (A/G)
Genotype TT TG GG AA AG GG
OPLL (n = 57) 38 19 0 1 15 41
Control (n = 135) 126 9 0 0 23 112
Fisher’s exact test P\0.001 P = 0.081
Allele T G A G
OPLL 95 19 17 97
Control 261 9 23 247
Fisher’s exact test P\0.001 P = 0.069
Note: Difference in genotypic and allelic distribution between sub-
population of OPLL patients and controls were analyzed using v
2-test
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123The numbers of the ‘‘TT,’’ ‘‘TG,’’ and ‘‘GG’’ genotypes
of the Ser37Ala (T/G) in this study population were 164,
28, and 0, and the frequencies were 85, 15, and 0%,
respectively. The numbers of the ‘‘AA,’’ ‘‘AG,’’ and ‘‘GG’’
genotypes of the Ser87Ser (A/G) in this study population
were 1, 38, and 153, and the frequencies were 0.005, 19.79,
and 79.69, respectively.
Comparing the distributions of genotype of two SNPs,
there was statistical difference among the ‘‘TT,’’ ‘‘TG,’’
and ‘‘GG’’ in the Ser37Ala (T/G) polymorphism (Fisher’s
exact P\0.001). The ‘‘TG’’ genotype is associated with
the occurrence of OPLL. There was no statistical difference
among the ‘‘TT,’’ ‘‘TC,’’ and ‘‘CC’’ genotypes in the
Ser87Ser (A/G) polymorphism (Fisher’s exact P = 0.081).
No association was found between male and female
Ser87Ser (A/G) genotypes in cases (Fisher’s exact
P = 0.366).
Comparing the distributions of allele type of two SNPs,
there was a signiﬁcant association between the Ser37Ala
(T/G) polymorphism and the occurrence of OPLL in the
cervical spine. The studies show that the frequency of the
‘‘G’’ allele is signiﬁcantly higher in subjects with OPLL
than in control subjects (Fisher’s exact P\0.001). How-
ever, there was no statistical difference between the
Ser87Ser (A/G) polymorphism and the occurrence of
OPLL in the cervical spine (Fisher’s exact P = 0.069). In
addition, the Ser87Ser (A/G) SNP in male patients (Fish-
er’s exact P = 0.102) and female patients (Fisher’s exact
P = 0.117) of the cases was not signiﬁcantly associated
with controls. There were no allelic frequency differences
between males and females in control groups (Fisher’s
exact P = 1.000). The Ser87Ser (A/G) polymorphism in
male patients (Fisher’s exact P = 0.155) and in female
patients (Fisher’s exact P = 0.260) also showed no
Fig. 1 The plain radiographs
and sequencing results of a
62-year-old man with OPLL.
a The plain radiographs showed
patient had ossiﬁcation of the
posterior longitudinal ligament
in the cervical spine (C2–C4,
C5–C6, C7 mixed type). b The
direct sequencing result of the
PCR products showed the TG
heterozygosis mutation of the
Ser37Ala (T/G) polymorphism
in exon 2 of the BMP-2 gene.
A allele: green line; T allele: red
line; C allele: blue line; G allele:
black line
Fig. 2 The 2-dimensional
(2D)-computerized tomography
(CT) and sequencing results of a
50-year-old woman with OPLL.
a The 2D-CT showed patient
had ossiﬁcation of the posterior
longitudinal ligament in the
cervical spine (C2–C3, C4,
C5–C6 mixed type). b The
direct sequencing result of the
PCR products showed the AG
heterozygosis mutation of the
Ser87ser (A/G) polymorphism
in exon 2 of the BMP-2 gene.
A allele: green line; T allele: red
line; C allele: blue line; G allele:
black line
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123statistical difference between cases and controls. Table 2
shows genotypic and allelic distributions of Ser87Ser
(A/G) classiﬁed by gender in OPLL Patients and non-
OPLL Controls.
The distribution of ossiﬁed cervical vertebrae of OPLL
patients in each subgroup classiﬁed by genotype of two
SNPs is shown in Tables 3 and 4. The authors further
investigated the association of two SNPs with the number
of ossiﬁed cervical vertebrae in OPLL patients (Figs. 3, 4).
Regarding the Ser37Ala (T/G) polymorphism in the
BMP-2 gene, Patients with the ‘‘G’’ allele (genotype, ‘‘TG’’
or ‘‘GG’’) in the polymorphism showed no signiﬁcantly
greater number of ossiﬁed cervical vertebrae than those
without the ‘‘G’’ allele (genotype, TT; Mann–Whitney
exact P = 0.113). The ‘‘G’’ allele in the Ser37Ala (T/G)
polymorphism is not associated with the extent of hetero-
topic ossiﬁcation in the cervical spine in OPLL patients.
Regarding the Ser87Ser (A/G) polymorphism in the BMP-
2 gene, patients without the ‘‘A’’ allele (genotype, ‘‘GG’’)
in the Ser87Ser (A/G) polymorphism showed a signiﬁ-
cantly greater number of ossiﬁed cervical vertebrae than
those with the ‘‘A’’ allele (genotype, ‘‘AG’’ or ‘‘AA’’;
Mann–Whitney exact P\0.001). The present results
indicate that the ‘‘G’’ allele promotes the extent of OPLL,
whereas the ‘‘A’’ allele restricts ectopic ossiﬁcation in the
cervical spine in OPLL patients.
Discussion
OPLL of the spine is a subset of ‘‘bone-forming’’ diseases,
characterized by ectopic ossiﬁcation in the spine ligaments
[19, 20, 31]. OPLL is a common disorder among elderly
populations and is the leading cause of spinal myelopathy
in Asian populations [14]. The pathogenesis of OPLL
remains unknown. The etiologies of all complex diseases
potentially involve gene-gene and gene-environment
interactions. The OPLLs high concordance in twins [26].
and the association with particular human leukocyte anti-
gen haplotypes [15, 22] suggested that genetic factors may
be involved in its pathogenesis. The histopathologic fea-
tures of OPLL are characterized by the abnormal
expression of BMP-2, TGF-b, and Type I, II, and XI col-
lagens (COL11) in the regional ligament [5, 37]. Therefore,
multiple rather than single, dominant genes, including
COL11, BMP-2, TGF-b1, should be considered as candi-
date genes involved in the predisposition to OPLL. The
previous studies showed that the restriction fragment
length polymorphism (RFLP) of estrogen receptor (ER)
gene, interleukin-1 (IL-1) gene, and the SNPs of TGF-b
gene, NPPS gene, Leptin Receptor gene, and COL11A2
gene are associated with the development of OPLL [10, 17,
25].
BMP-2 is one of the members of TGF-b superfamily
and acts as a potent stimulator of bone formation in vivo. In
addition, immunohistochemical studies demonstrated that
BMP-2 and TGF-b are present at ossifying matrix and
chondrocytes of ossifying ligaments, and that only BMP-2
is localized at mesenchymal cells adjacent to these areas,
and that nonossiﬁed ligament does not contain these
growth factors. It is suggested that BMP-2 and TGF-b
might play an important role during the development of
OPLL and that these factors play different roles at different
stages of development of ectopic ossiﬁcation [5].
BMP-2 gene, on chromosome 20p, contains three exons.
Exon 1 comprises a 50 untranslated region and exon 2
contains a hydrophobic leader sequence followed by 118
amino acids. Exon 3 encodes 283 amino acids, of which the
terminal 114 amino acids constitute the mature protein [21,
35]. BMP-2 gene has been considered to be a likely can-
didate involved in the OPLL pathogenesis. However, a
previous study reported no signiﬁcant association between
the RFLP of BMP-2 polymorphism and the prevalence of
OPLL in the cervical spine. The authors concluded that two
RFLPs of the BMP-2 allele were identiﬁed by digestion
with MspI and TaqI, which revealed alleles of 3.0 and
0.6 kb, and 2.5 and 2.1 kb, respectively. The genotype
Table 2 Genotypic and allelic distributions of Ser87Ser (A/G)
classiﬁed by gender in OPLL patients and non-OPLL Controls
SNPs Ser87Ser (A/G)
Genotype AA AG GG
OPLL (n = 57)
Male (n = 32) 0 10 22
Female (n = 25) 1 5 19
Fisher’s Exact Test P = 0.366
Control (n = 135) 0 23 112
Male (n = 85) 0 15 70
Female (n = 50) 0 8 42
Allele G A
OPLL
Male 54 10
Female 43 7
Control 247 23
Male 155 15
Female 92 8
Note: Difference in genotypic and allelic distribution classiﬁed by
gender between OPLL patients and controls were analyzed using
v
2-test
Male of OPLL and control, Fisher’s exact P = 0.102
Male of OPLL and male of controls, Fisher’s Exact P = 0.155
Female of OPLL and control, Fisher’s exact P = 0.117
Female of OPLL and female of controls, Fisher’s exact P = 0.260
Male and female in controls, Fisher’s exact test = 1.000
960 Eur Spine J (2008) 17:956–964
123frequency of MspI and TaqI alleles was not signiﬁcantly
different between the patients with OPLL and the control
subjects [6]. However, their study included only 18 patients
with OPLL and did not further research the single nucleo-
tide polymorphisms of BMP-2 gene. In this study,
oligonucleotide primers, the forward primer starting at
nucleotide 122109 of the BMP-2 gene (Genbank accession
number AL035668) and the reverse primer starting at
nucleotide 122502 of the BMP-2 gene, amplify the BMP-2
gene mRNA sequence in exon 2.
The current studies show that the Ser37Ala (T/G)
polymorphism in exon 2 of BMP-2 gene is associated with
the occurrence of OPLL, but not with more extensive
OPLL in the cervical spine. The ‘‘TG’’ genotype is asso-
ciated with the occurrence of OPLL. The results indicate
that the ‘‘G’’ allele is a risk factor associated with the
genetic susceptibility to OPLL, but not a factor related to
the extent of heterotopic ossiﬁcation in the cervical spine.
Previously, the studies described that the Ser37Ala (T/G)
polymorphism shows signiﬁcant association with osteo-
porosis [24]. The present results demonstrate that the
Ser37Ala (T/G) polymorphism in the BMP-2 gene initiates
the ectopic ossiﬁcation during the development of OPLL.
The present studies show that the Ser87Ser (A/G)
polymorphism in the BMP-2 gene is associated with more
extensive OPLL, but not with its occurrence rate in the
cervical spine. The ‘‘G’’ allele in the Ser87Ser (A/G)
polymorphism promotes the extent of OPLL, but does not
promote an increased susceptibility to OPLL. Patients not -
carrying the ‘‘A’’ allele in the Ser87Ser (A/G) polymor-
phism showed a greater number of ossiﬁed vertebrae than
the ‘‘A’’ allele-carrier patients. These results indicate that
the ‘‘G’’ allele promotes the extent of OPLL, whereas the
‘‘A’’ allele restricts ossiﬁcation. Furthermore, the analysis
adjusted for gender showed that the Ser87Ser (A/G)
polymorphism in male patients and in female patients
showed no statistical difference between the OPLL groups
and the control groups. The present results demonstrate the
Ser87Ser (A/G) polymorphism promotes the extent of
ectopic ossiﬁcation during the development of OPLL. The
Ser87Ser (A/G) SNP is samesense mutation. The authors
found that Chinese do not carry commonly the ‘‘AA’’
genotype but the ‘‘GG’’ or ‘‘AG’’ genotype in the Ser87Ser
(A/G) polymorphism. Only one ‘‘AA’’ genotype was found
in our samples. The patient with ‘‘AA’’ genotype showed
ossiﬁcation of the posterior longitudinal ligament in the
cervical spine (C4, C5 segmental type). However, the
patient did not have any clinical symptom. On the other
hand, the ‘‘G’’ allele in the Ser87Ser (A/G) polymorphism
is a risk genetic factor for the extent of OPLL in this study.
Therefore, the results may be beneﬁt to clarify that OPLL
is a common disorder among Asian populations. In addi-
tion, the Gln89Glu (C/G) polymorphism was found by
chance in this study. However, the present studies showed
only one patient had the Gln89Glu (C/G) polymorphism in
all samples. The patient with ‘‘CG’’ genotype hetero-
zygosis mutation in the Gln89Glu (C/G) polymorphism
showed the OPLL in the cervical spine (C2-C3, C4 mixed
Table 3 The distribution of ossiﬁed cervical vertebrae of OPLL
patientsineachsubgroupclassiﬁedby‘‘G’’alleleoftheSer37Ala(T/G)
Group 1 = G allele (+) Group 2 = G allele (-)
Number of
OPLL
patients
Number of
ossiﬁed
cervical
vertebrae
Number of
OPLL patients
Number of
ossiﬁed
cervical
vertebrae
12 1 1
26 2 2
33 3 3
42 4 2
52 5 1
61 6 3
73 7 2
81 8 2
92 9 5
10 1 10 3
11 1 11 4
12 2 12 2
13 2 13 3
14 6 14 3
15 1 15 2
16 3 16 3
17 2
18 1
19 7
20 7
21 3
22 4
23 3
24 1
25 3
26 2
27 3
28 2
29 2
30 5
31 3
32 3
33 3
34 2
35 1
36 2
37 7
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123type). No signiﬁcant association was found between the
OPLL and the control groups.
Several limitations of this study are noted. Firstly, we
did not fully cover all genetic variation in the BMP-2 gene
analyzed, and only common variants were studied.
Therefore, if rare variants of this gene were involved in the
pathogenesis of OPLL, we might have missed them. Sec-
ondly, we only analyzed the patients with OPLL in the
cervical spine and excluded the patients with OPLL in the
thoracic and/or lumbar spine in the present study. But it is
possible that two SNPs in BMP-2 gene affect the bone
formation not only in cervical spine, but also in thoracic or
lumbar spine in the patients with OPLL. Therefore, based
Table 4 The distribution of ossiﬁed cervical vertebrae of OPLL
patientsineachsubgroupclassiﬁedby‘‘A’’alleleoftheSer87Ser(A/G)
Group 1 = A allele (+) Group 2 = A allele (-)
Number of
OPLL
patients
Number of
ossiﬁed
cervical
vertebrae
Number of
OPLL
patients
Number of
ossiﬁed
cervical
vertebrae
12 1 1
22 2 2
32 3 3
41 4 1
52 5 3
61 6 6
72 7 2
81 8 5
92 9 3
10 2 10 6
11 2 11 2
12 2 12 3
13 2 13 3
14 1 14 3
15 2 15 2
16 3
17 2
18 1
19 7
20 7
21 3
22 4
23 3
24 1
25 3
26 3
27 4
28 2
29 3
30 3
32 1
33 3
34 5
35 3
36 7
37 2
38 1
Fig. 3 The number of ossiﬁed vertebrae of OPLL patients in each
subgroup classiﬁed by genotype of the Ser37Ala (T/G). Data are
expressed as means (bars) ± SEM (error bars). The number of
patients is shown under each bar. The difference in the number of
ossiﬁed vertebrae between carriers (group 1) and noncarriers (group
2) of deletion G allele was statistically analyzed. P[0.05, N.S., not
signiﬁcant
Fig. 4 The number of ossiﬁed vertebrae of OPLL patients in each
subgroup classiﬁed by genotype of the Ser87Ser (A/G). Data are
expressed as means (bars) ± SEM (error bars). The number of
patients is shown under each bar. The difference in the number of
ossiﬁed vertebrae between carriers (group 1) and noncarriers (group
2) of deletion A allele was statistically analyzed. ** P\0.001
962 Eur Spine J (2008) 17:956–964
123on the present study, the authors are going to functionally
analyze the difference in the distribution of the BMP-2
polymorphism between the group with OPLL throughout
the spine and the group with isolated cervical OPLL in the
future. Thirdly, although OPLL of the spine is a common
disorder among Japanese and other Asian populations, the
present results only drawn in Chinese cannot be genera-
lized to Korean, Japanese, Caucasian populations.
Therefore, additional studies are required to elucidate the
contribution of two SNPs of BMP-2 gene to the develop-
ment of ectopic ossiﬁcation in other ethnic groups.
The functional impact of two SNPs of BMP-2 gene is
uncertain, but BMP-2 may lead to increased bone mass in
the posterior longitudinal ligament of the cervical spine.
The most likely explanation for this is two SNPs varia-
tions may yield the alternative transcript and translation
with abnormal function and further cause the over-
expression of BMP-2 protein in the posterior longitudinal
ligament matrix. Several investigations have demonstrated
a precise balance to exist between BMP agonists and
antagonists, dictating BMP signaling and osteogenesis.
The interaction of BMP with the receptor chains is under
stringent control of modulator proteins that bind to the
ligand and, by blocking it, prevent receptor activation and
signaling [1, 3, 13]. These proteins form three distinct
families, the noggin, chordin-SOG, and DAN-cerberus
families [2]. The overexpression of BMP-2 protein in the
posterior longitudinal ligament matrix can augment the
signaling activity of endogenously produced BMPs. Fur-
ther the posterior longitudinal ligament matrix has an
imbalance between the expression of BMP-2 agonists and
the potential existence of antagonists. Thus BMP-2 pro-
tein may be more refractory to inhibitors such as noggin.
BMP antagonists are capable of downregulating BMP
signal. BMP signal requires the binding of two types of
receptor serine/threonine kinases [4, 23]. Three type I
receptors (BMP receptor type IA, BRIA, and type IB,
BRIB, and activin type I, ActRI) and two type II (BMP
receptor type II, BRII, and activin type II, ActRII)
receptors are currently known to bind BMP-2 signal [9,
12, 29]. In addition, previous immunohistochemical study
reported that BMPRS and ActRs are highly expressed in
ectopic ossiﬁed ligaments of patients with OPLL. The
receptors were not expressed in a posterior longitudinal
ligament from non-OPLL patients. Enhanced expression
of BMPRS at the nonossiﬁed ligament in OPLL patients
suggests that these cells have a greater potential to dif-
ferentiate into osteogenic cells than ligament cells from
non-OPLL patients [38]. Collectively, augmented BMP-2
signal via the high expression of BMPRS and ActRs in
the ectopic ossiﬁed ligaments suggests that BMP-2 pro-
tein is more active and may be tightly involved in the
pathological ossiﬁcation process of OPLL.
In conclusion, the present results demonstrate that the
polymorphisms in the BMP-2 gene are not only a factor
associated with the occurrence of OPLL, but also a factor
related to more extensive OPLL. The ‘‘TG’’ genotype in
the Ser37Ala (T/G) polymorphism is associated with the
occurrence of OPLL. The ‘‘G’’ allele in the Ser37Ala (T/G)
polymorphism is associated with the occurrence of OPLL,
but not with the extent of OPLL. The ‘‘G’’ allele in the
Ser87Ser (A/G) polymorphism promotes the extent of
OPLL, but does not promote an increased susceptibility to
OPLL, whereas the ‘‘A’’ allele in the Ser87Ser (A/G)
polymorphism restricts ectopic ossiﬁcation at least in
Chinese subjects. The current studies will beneﬁt to clarify
the molecular etiology of OPLL. The understanding of the
molecular etiology of OPLL will lead to the development
of new therapeutic approaches to the disease.
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